| |
| |
|
| Insider
Information: |
Howton David T |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
48,826 |
|
|
Indirect Shares
|
264 |
|
|
| Direct
Value |
$7,746,679 |
|
|
|
Indirect Value
|
$103,702 |
|
|
| Total
Shares |
49,090 |
|
|
| Total
Value |
$7,850,381 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
SVP |
2011-09-01 |
9,271 |
2011-09-01 |
264 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
EVP, General Counsel |
2020-06-22 |
31,871 |
2016-02-29 |
0 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
|
2023-12-04 |
7,684 |
2023-12-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLDB |
Solid Biosciences Inc |
Chief Operating Officer |
• – – |
2023-12-04 |
4 |
AS |
$2.78 |
$14,920 |
D/D |
(5,367) |
7,684 |
0 |
% |
|
| SLDB |
Solid Biosciences Inc |
Chief Operating Officer |
• – – |
2023-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,051 |
13,051 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2020-06-22 |
4 |
AS |
$168.61 |
$17,962,831 |
D/D |
(105,122) |
31,871 |
0 |
% |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2020-06-22 |
4 |
OE |
$13.71 |
$2,708,440 |
D/D |
105,122 |
136,993 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,700 |
31,871 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2019-12-13 |
4 |
AS |
$125.50 |
$9,789,000 |
D/D |
(78,000) |
25,171 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2019-12-13 |
4 |
OE |
$13.90 |
$1,675,439 |
D/D |
78,000 |
103,171 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2019-11-22 |
4 |
AS |
$105.00 |
$2,625,000 |
D/D |
(25,000) |
11,993 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2019-11-22 |
4 |
OE |
$13.71 |
$552,667 |
D/D |
34,272 |
27,975 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2019-11-22 |
4 |
D |
$107.02 |
$300,084 |
D/D |
(2,804) |
25,171 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2019-03-28 |
4 |
D |
$118.68 |
$280,322 |
D/D |
(2,362) |
18,703 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2019-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,319 |
21,065 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, General Counsel |
• – – |
2019-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,825) |
15,746 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2019-02-01 |
4 |
OE |
$13.71 |
$465,391 |
D/D |
21,500 |
49,571 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2019-02-01 |
4 |
AS |
$140.00 |
$4,200,000 |
D/D |
(30,000) |
19,571 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2018-08-08 |
4 |
D |
$121.02 |
$822,936 |
D/D |
(6,800) |
28,071 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2018-07-16 |
4 |
AS |
$136.46 |
$6,823,000 |
D/D |
(50,000) |
34,871 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2018-07-16 |
4 |
OE |
$13.71 |
$692,691 |
D/D |
50,000 |
72,719 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2018-05-22 |
4 |
D |
$89.22 |
$139,719 |
D/D |
(1,566) |
34,871 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2018-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,319 |
36,437 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2018-03-15 |
4 |
D |
$81.22 |
$55,230 |
D/D |
(680) |
31,118 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2018-03-15 |
4 |
OE |
$13.71 |
$55,382 |
D/D |
2,500 |
31,727 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2017-08-03 |
4 |
D |
$37.88 |
$175,839 |
D/D |
(4,642) |
29,298 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2017-08-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,639 |
33,940 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
SVP, General Counsel |
• – – |
2017-07-21 |
4 |
OE |
$13.71 |
$20,565 |
D/D |
1,000 |
23,301 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
